ABVC News and Press, ABVC BioPharma Inc. From 11/14/19

  PDC-1421 high-dose data meets primary endpoint on MADRS scale in ITT clinical trial population PDC-1421 low-dose and PDC-1421 high-dose each proved safe, were well-tolerated, and had no serious adverse events associated with them in Phase II clinical trial Company is...

·          Dr. Andrew Chang, principal investigator, recently presented encouraging feasibility study results from Vitargus® at the AAO 2019 Annual Meeting ·          Study results sugges...

·          Dr. Andrew Chang, principal investigator, recently presented encouraging feasibility study results from Vitargus® at the AAO 2019 Annual Meeting ·          Study results s...

·          Dr. Andrew Chang, principal investigator, will present encouraging results on Vitargus® from recently completed feasibility study ·          Company to initiate multi-national,...

·          Dr. Andrew Chang, principal investigator, will present encouraging results on Vitargus® from recently completed feasibility study ·          Company to initiate multi-nati...

American BriVision ( OTCQB:ABVC -2.2% ) announced that as of September 1, Mr. Chihliang “Andy” An was appointed as the Company’s new CFO. More news on: American BriVision (Holding) Corporation, Read more ...

FREMONT, CA, Oct. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American BriVision (Holding) Corporation (OTCQB: ABVC) (the “Company”), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, is pleased to ...

Fremont, CA, Sept. 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American BriVision (Holding) Corporation (OTCQB:  ABVC ) (the “Company”), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, toda...

American BriVision ( OTCQB:ABVC -0.2% ) inks an exclusive global research collaboration and license agreement with BioLite Japan aimed at identifying early-stage opportunities in drug development, digital health and medical device technology. More news on: American BriVision (Holding) ...

  Collaboration combines BioLite Japan’s early-stage discovery capabilities with the Company’s clinical trial expertise   BioLite Japan’s expertise in academic and medical community in Japan and APAC  region brings new development candidates to ...